White label – Pompe disease - ClinicalTrials.eu

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Not recruiting

3 1 1
Investigated Drugs:
+7
Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Ovarian cancer recurrent
Investigated Drugs:
+4
Study of LY3871801 for Adults with Moderate to Severe Rheumatoid Arthritis

Not recruiting

2 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Ly3871801
Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Renal cell carcinoma
Investigated Drugs:
- Lenvatinib
- Pembrolizumab
Study on Brain Inflammation in Stroke Patients Using Ficolin-2, Gadoteric Acid, and 18F-DPA-714

Not recruiting

2 1 1 1
Investigated Diseases:
- Transient ischaemic attack
- Cerebrovascular accident
Investigated Drugs:
- N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
- Gadoteric Acid
Study of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin

Not recruiting

3 1 1
Investigated Diseases:
- Head and neck cancer
Investigated Drugs:
- Xevinapant
- Cetuximab
Study of Nivolumab, Ipilimumab, or Cabazitaxel for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
- Prostate cancer metastatic
Investigated Drugs:
Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Not recruiting

3 1
Investigated Drugs:
- Rifaximin
+2
Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Olaparib
- Pembrolizumab
+2
Study on Secukinumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Non-Type 2 Patients

Not recruiting

3 1 1 1
Investigated Drugs:
- Secukinumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies